[ Price : $8.95]
Federal Register notice: FDA makes available a guidance on notifying FDA about a permanent discontinuance or interruption in produ...[ Price : $8.95]
Federal Register notice: FDA announces a 6/8 ophthalmic devices advisory committee meeting that will review a Refocus Group PMA fo...[ Price : $8.95]
FDA warns Bulgarias Ficosota drug manufacturing firm about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA warns Trilogy Laboratories about CGMP, new drug, and misbranding violations in its production of finished drugs.[ Price : $8.95]
Psychiatrist David Behar petitions FDA to remove the clozapine REMS program and allow providers to use their clinical judgment in ...[ Price : $8.95]
FDA warns Pfizer Healthcare India about a CGMP violation in its production of finished drugs.[ Price : $8.95]
CME America recalls the BodyGuard Infusion Pump Systems because the pumps may under or over infuse medications.[ Price : $8.95]
PhRMA submits additional comments on the FDA 2/24 Rare Disease Day public meeting.